Bibliografia UJ CM

1/17
F. Heinen, M[arta] Banach, E. Dabrowski, D. Gaebler-Spira, H. Chambers, S. Schroeder, T. Geister, M. Althaus, A. Hanschmann, S. Berweck.
Lack of immunogenicity of incobotulinumtoxinA in pediatrics : a pooled analysis
Movement Disorders
2022 : Vol. 37, suppl. 1
2022 International Congress, Madrid, Spain, 15-18 September 2022.
p-ISSN: 0885-3185
e-ISSN: 1531-8257
SZZ
SIF
Adres url:
2/17
F. Heinen, M[arta] Banach, E. Dabrowski, D. Gaebler-Spira, H. Chambers, S. Schroeder, T. Geister, M. Althaus, A. Hanschmann, S. Berweck.
Safety of incobotulinumtoxinA in pediatrics : a pooled analysis
Movement Disorders
2022 : Vol. 37, suppl. 1
2022 International Congress, Madrid, Spain, 15-18 September 2022.
p-ISSN: 0885-3185
e-ISSN: 1531-8257
SZZ
SIF
Adres url:
3/17
H. Chambers, P. Kanovsky, A. Schroeder, E. Dabrowski, T. Geister, A. Hanschmann, I. Pulte, M. Althaus, M[arta] Banach, D. Gaebler-Spira, F. Heinen.
Absence of neutralizing antibodies with incobotulinumtoxinA for spasticity in botulinum toxin-naive children with cerebral palsy.
Developmental Medicine and Child Neurology
2021 : Vol. 63, suppl. 3, s. 75-76, abstr. SP15
American Academy for Cerebral Palsy and Developmental Medicine, 6-9 October 2021.
p-ISSN: 0012-1622
e-ISSN: 1469-8749
SZZ
SIF
Adres url:
DOI:
4/17
H. Chambers, P. Kanovsky, A. Schroeder, E. Dabrowski, T. Geister, A. Hanschmann, I. Pulte, M. Althaus, M[arta] Banach, D. Gaebler-Spira, F. Heinen.
Absence of neutralizing antibody formation during incobotulinumtoxinA treatment of spasticity in botulinum toxin-naive children with cerebral palsy : pooled analysis of phase 3 studies.
Movement Disorders
2021 : Vol. 36, suppl. 1, s. S29-S30, abstr. 67
MDS Virtual Congress 2021, 17-22 September 2021.
p-ISSN: 0885-3185
e-ISSN: 1531-8257
SZZ
SIF
Adres url:
5/17
E. Dabrowski, H. Chambers, D. Gaebler-Spira, M[arta] Banach, P. Kanovsky, A. Hanschmann, M. Althaus, T. Geister, F. Heinen.
Efficacy and safety of incobotulinumtoxinA for upper- or combined upper- and lower-limb spasticity in children/adolescents with cerebral palsy : the XARA study.
Movement Disorders
2021 : Vol. 36, suppl. 1, s. S31, abstr. 71
MDS Virtual Congress 2021, 17-22 September 2021.
p-ISSN: 0885-3185
e-ISSN: 1531-8257
SZZ
SIF
Adres url:
6/17
A. Schroeder, P. Kanovsky, H. Chambers, E. Dabrowski, T. Geister, A. Hanschmann, I. Pulte, M[arta] Banach, D. Gaebler-Spira, F. Heinen.
Efficacy of incobotulinumtoxinA over six injection cycles for lower-limb spasticity in children/adolescents with cerebral palsy.
Developmental Medicine and Child Neurology
2021 : Vol. 63, suppl. 3, s. 85, abstr. SP34
American Academy for Cerebral Palsy and Developmental Medicine, 6-9 October 2021.
p-ISSN: 0012-1622
e-ISSN: 1469-8749
SZZ
SIF
Adres url:
DOI:
7/17
F. Heinen, P. Kanovsky, A. Schroeder, H. Chambers, E. Dabrowski, T. Geister, A. Hanschmann, I. Pulte, M. Althaus, M[arta] Banach, D. Gaebler-Spira.
Improvement of spasticity-related pain with incobotulinumtoxinA treatment in children/adolescents with cerebral palsy : pooled analysis of phase 3 studies.
Movement Disorders
2021 : Vol. 36, suppl. 1, s. S33-S34, abstr. 75
MDS Virtual Congress 2021, 17-22 September 2021.
p-ISSN: 0885-3185
e-ISSN: 1531-8257
SZZ
SIF
Adres url:
8/17
F. Heinen, M. Bonfert, P. Kanovsky, S. Schroeder, H. Chambers, E. Dabrowski, T. Geister, A. Hanschmann, M. Althaus, M[arta] Banach, D. Gaebler-Spira.
Improvements in lower limb spasticity-related pain in children/adolescents with cerebral palsy after incobotulinumtoxinA injections
Movement Disorders
2021 : Vol. 36, suppl. 1, s. S248
MDS Virtual Congress 2021, 17-22 September 2021.
p-ISSN: 0885-3185
e-ISSN: 1531-8257
SZZ
SIF
9/17
F. Heinen, M. Bonfert, P. Kanovsky, S. Schroeder, H. Chambers, E. Dabrowski, T. Geister, A. Hanschmann, M[arta] Banach, D. Gaebler-Spira.
Improvements in upper limb spasticity-related pain in children/adolescents with cerebral palsy after incobotulinumtoxinA injections
Movement Disorders
2021 : Vol. 36, suppl. 1, s. S249
MDS Virtual Congress 2021, 17-22 September 2021.
p-ISSN: 0885-3185
e-ISSN: 1531-8257
SZZ
SIF
10/17
E. Dabrowski, H. Chambers, D. Gaebler-Spira, M[arta] Banach, P. Kanovsky, A. Hanschmann, M. Althaus, T. Geister, F. Heinen.
IncobotulinumtoxinA for upper-/lower-limb spasticityin children/adolescents with cerebral palsy : phase 3 Xara study.
Developmental Medicine and Child Neurology
2021 : Vol. 63, suppl. 3, s. 69, abstr. SP01
American Academy for Cerebral Palsy and Developmental Medicine, 6-9 October 2021.
p-ISSN: 0012-1622
e-ISSN: 1469-8749
SZZ
SIF
Adres url:
DOI:
11/17
P. Kanovsky, D. Gaebler-Spira, A. Schroeder, H. Chambers, E. Dabrowski, T. Geister, A. Hanschmann, I. Pulte, M. Althaus, M[arta] Banach, F. Heinen.
Pooled analysis of incobotulinumtoxinA for upper-/lower-limb spasticity in children with severe cerebral palsy (GMFCS level IV-V).
Developmental Medicine and Child Neurology
2021 : Vol. 63, suppl. 3, s. 88-89, abstr. SP41
American Academy for Cerebral Palsy and Developmental Medicine, 6-9 October 2021.
p-ISSN: 0012-1622
e-ISSN: 1469-8749
SZZ
SIF
Adres url:
DOI:
12/17
F. Heinen, P. Kanovsky, A. Schroeder, H. Chambers, E. Dabrowski, T. Geister, A. Hanschmann, I. Pulte, M. Althaus, M[arta] Banach, D. Gaebler-Spira.
Pooled efficacy analysis of incobotulinumtoxinA forupper- and lower-limb spasticity in children/adolescents with cerebral palsy.
Developmental Medicine and Child Neurology
2021 : Vol. 63, suppl. 3, s. 80-81, abstr. SP25
American Academy for Cerebral Palsy and Developmental Medicine, 6-9 October 2021.
p-ISSN: 0012-1622
e-ISSN: 1469-8749
SZZ
SIF
Adres url:
DOI:
13/17
P. Kanovsky, D. Gaebler-Spira, A. Schroeder, H. Chambers, E. Dabrowski, T. Geister, A. Hanschmann, I. Pulte, M. Althaus, M[arta] Banach, F. Heinen.
Pooled efficacy and safety analysis of incobotulinumtoxinA for upper- and lower-limb spasticity in children with severe cerebral palsy (GMFCS levels IV-V).
Movement Disorders
2021 : Vol. 36, suppl. 1, s. S34, abstr. 76
MDS Virtual Congress 2021, 17-22 September 2021.
p-ISSN: 0885-3185
e-ISSN: 1531-8257
SZZ
SIF
Adres url:
14/17
F. Heinen, M. Bonfert, P. Kanovsky, S. Schroeder, H. Chambers, E. Dabrowski, T. Geister, A. Hanschmann, M. Althaus, M[arta] Banach, D. Gaebler-Spira.
Prevalence of spasticity-related pain in children/adolescents with cerebral palsy
Movement Disorders
2021 : Vol. 36, suppl. 1, s. S251
MDS Virtual Congress 2021, 17-22 September 2021.
p-ISSN: 0885-3185
e-ISSN: 1531-8257
SZZ
SIF
15/17
M[arta] Banach, P. Kanovsky, A. Schroeder, H. Chambers, E. Dabrowski, T. Geister, A. Hanschmann, I. Pulte, M. Althaus, D. Gaebler-Spira, F. Heinen.
Safety of incobotulinumtoxinA for upper- and lower-limb spasticity in children/adolescents with cerebralpalsy : phase 3 analysis.
Developmental Medicine and Child Neurology
2021 : Vol. 63, suppl. 3, s. 80, abstr. SP24
American Academy for Cerebral Palsy and Developmental Medicine, 6-9 October 2021.
p-ISSN: 0012-1622
e-ISSN: 1469-8749
SZZ
SIF
Adres url:
DOI:
16/17
M[arta] Banach, P. Kanovsky, S. Schroeder, H. Chambers, E. Dabrowski, T. Geister, A. Hanschmann, I. Pulte, M. Althaus, D. Gaebler-Spira, F. Heinen.
Safety of incobotulinumtoxinA in multipattern treatment of upper- and lower-limb spasticity in children/adolescents with cerebral palsy: pooled analysis of 3 large phase 3 studies
Movement Disorders
2021 : Vol. 36, suppl. 1, s. 261
MDS Virtual Congress 2021, 17-22 September 2021.
p-ISSN: 0885-3185
e-ISSN: 1531-8257
SZZ
SIF
17/17
S. Schroeder, P. Kanovsky, H. Chambers, E. Dabrowski, T. Geister, A. Hanschmann, I. Pulte, M[arta] Banach, D. Gaebler-Spira, F. Heinen.
Sustained efficacy of incobotulinumtoxinA over 6 injection cycles for the treatment of lower-limb spasticity in children and adolescents with cerebral palsy
Movement Disorders
2021 : Vol. 36, suppl. 1, s. 263
MDS Virtual Congress 2021, 17-22 September 2021.
p-ISSN: 0885-3185
e-ISSN: 1531-8257
SZZ
SIF
Wyświetl ponownie stosując format:

Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ